PeptidePedia The community reference

Contributions of EndotoxinEd

User contributions·78 logged edits·page 1 of 1

Contributions by EndotoxinEd, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 15,330 edits includes activity predating the current log.

  1. 18:00, 26 Jul 2026 (diff | hist) Thermo Fisher Scientific (China) 18,353 ±0 clarify that no manufacturing or marketing authorisation is claimed or established
  2. 13:17, 21 Jul 2026 (diff | hist) Asymchem Laboratories 3,977 +795 close an unbalanced quotation mark
  3. 07:32, 21 Jul 2026 (diff | hist) PolyPeptide Group (Hangzhou) 18,365 +2 m add the incorporation year, attributed to the registry record
  4. 16:17, 28 Jun 2026 (diff | hist) Xi'an Mokemei Biotechnology 15,421 ±0 m add the incorporation year, attributed to the registry record
  5. 03:45, 24 Jun 2026 (diff | hist) Shenzhen Hybio Pharmaceutical 17,716 ±0 label the reception tally as weak, self-selected evidence at this point of use
  6. 08:49, 18 Jun 2026 (diff | hist) Nantong Guangyuan Chemical 15,114 ±0 m add the standing talk-page note link to the banner
  7. 14:03, 8 Jun 2026 (diff | hist) Talk:Multi-dose vial 1,159 +286 /* Preservative concentration table: are these current products or historical? */ reply
  8. 14:00, 12 May 2026 (diff | hist) Talk:Sterility testing 748 +122 /* Method suitability */ reply
  9. 15:56, 26 Apr 2026 (diff | hist) Underfilling 4,882 ±0 add the citation for the blind-sampling discussion
  10. 21:46, 19 Apr 2026 (diff | hist) GenScript Peptides 17,833 ±0 rm the adjective — an organisation article describes, it does not praise
  11. 06:38, 19 Apr 2026 (diff | hist) SinoPep 18,360 ±0 m add the outbound storefront link, marked nofollow and sponsored per the external-links convention
  12. 09:07, 15 Apr 2026 (diff | hist) Talk:Beyond-use date 1,370 +287 /* Community dating practice: describe or omit? */ reply
  13. 02:29, 13 Apr 2026 (diff | hist) ChinaPeptides 14,979 ±0 expand §Product range
  14. 10:20, 11 Apr 2026 (diff | hist) Talk:Peptide harm reduction 537 +123 /* Sterility is categorical */ new section
  15. 06:14, 11 Apr 2026 (diff | hist) Bachem Holding (Suzhou) 15,124 ±0 add the reception tally with its period and count stated
  16. 14:20, 6 Apr 2026 (diff | hist) Talk:Bacterial endotoxin test 748 +126 /* Recombinant factor C */ reply
  17. 08:44, 4 Apr 2026 (diff | hist) Talk:Cold chain 1,792 +368 /* RfC: should this article cover consumer shipping practice? */ reply
  18. 13:20, 2 Apr 2026 (diff | hist) Talk:USP General Chapter 71 611 +156 /* Pore size is a convention */ reply
  19. 16:22, 30 Mar 2026 (diff | hist) Talk:Multi-dose vial 1,022 +314 /* Weight of the outbreak section */ reply
  20. 13:40, 17 Mar 2026 (diff | hist) Talk:USP General Chapter 85 611 +147 /* Tested by versus meets the limit */ reply
  21. 10:20, 11 Mar 2026 (diff | hist) Talk:Sterile water for injection 400 +175 /* Sterility does not transfer */ new section
  22. 09:26, 3 Mar 2026 (diff | hist) Chinese Peptide Company 15,513 ±0 m expand §Reception
  23. 13:20, 19 Feb 2026 (diff | hist) Talk:Bacteriostatic water 611 +105 /* The three misunderstandings */ reply
  24. 18:03, 16 Feb 2026 (diff | hist) Shanghai Wibson Biotechnology 15,440 ±0 m state what the certificate supplied with orders carries
  25. 19:46, 8 Feb 2026 (diff | hist) C-peptide 4,400 ±0 rm the extrapolation from a research assay to a clinical one
  26. 13:30, 1 Feb 2026 (diff | hist) Talk:Sterility testing 611 +193 /* The detection-probability table */ reply
  27. 09:30, 23 Jan 2026 (diff | hist) Talk:Bacterial endotoxin test 400 +169 /* Sterile but pyrogenic */ new section
  28. 12:34, 20 Jan 2026 (diff | hist) Talk:Multi-dose vial 885 +312 /* Does adding bacteriostatic water make a preparation preserved? */ reply
  29. 23:07, 10 Jan 2026 (diff | hist) Reconstitution calculator 8,662 ±0 m add the caveat that concentration and dose are not the same quantity
  30. 14:57, 29 Dec 2025 (diff | hist) Crude peptide 4,775 ±0 de-duplicate a repeated sentence
  31. 16:40, 9 Dec 2025 (diff | hist) Talk:Karl Fischer titration 885 +221 /* Merge proposal: Loss on drying into this article */ reply
  32. 03:11, 19 Nov 2025 (diff | hist) AmbioPharm 7,964 +201 add the catalogue size and label it self-reported
  33. 16:41, 6 Nov 2025 (diff | hist) GenScript Peptides 8,933 +352 add the see-also to the certificate-of-analysis article
  34. 15:23, 30 Oct 2025 (diff | hist) Counterfeit peptide 5,488 +259 m expand §Substitution
  35. 09:25, 16 Oct 2025 (diff | hist) Lot traceability 5,317 ±0 add the cost basis, since it shapes who submits
  36. 13:04, 14 Oct 2025 (diff | hist) Shenzhen Hybio Pharmaceutical 8,152 +399 fix a broken wikilink
  37. 00:28, 8 Oct 2025 (diff | hist) Weight regain after discontinuation 4,670 ±0 add the contraindication with its rationale
  38. 22:47, 30 Sep 2025 (diff | hist) Shenzhen Hybio Pharmaceutical 7,111 ±0 state the city and province of the registered address
  39. 18:12, 22 Sep 2025 (diff | hist) Sigma-Aldrich (Shanghai) Trading 13,171 +136 fix a dangling clause
  40. 17:14, 12 Sep 2025 (diff | hist) Shanghai ERP Biotechnology 6,332 +318 m expand §Product range
  41. 04:09, 28 Aug 2025 (diff | hist) Liquid chromatography-mass spectrometry 4,276 ±0 m clarify that mass spectrometry confirms identity, not purity
  42. 03:21, 23 Aug 2025 (diff | hist) Sangon Biotech 12,139 +592 m add the note that self-published material is usable only for what it states about itself
  43. 08:55, 20 Aug 2025 (diff | hist) Talk:Qingdao Saber Technology Pharmaceutical 959 +232 /* Appearance and purity are separate observations */ reply
  44. 11:57, 8 Aug 2025 (diff | hist) WuXi TIDES 14,644 +798 m copyedit
  45. 18:50, 28 Jul 2025 (diff | hist) Shanghai ERP Biotechnology 3,987 +197 state the city and province of the registered address
  46. 16:21, 23 Jul 2025 (diff | hist) Zhuhai Kerui Biotechnology 5,592 +201 add the note that self-published material is usable only for what it states about itself
  47. 19:17, 20 Jun 2025 (diff | hist) Sangon Biotech 8,781 +389 correct the trading name — the short code and the legal name are different things
  48. 05:42, 14 Jun 2025 (diff | hist) Drug master file 4,092 +750 add the jurisdiction to the legal statement
  49. 19:53, 3 Jun 2025 (diff | hist) Sangon Biotech 8,392 +853 rm a duplicated category
  50. 01:33, 22 May 2025 (diff | hist) Blind sampling 7,309 +529 correct the description of the sampling procedure
  51. 09:18, 7 May 2025 (diff | hist) Talk:Shanghai ERP Biotechnology 537 +266 /* Endotoxin results: worth a paragraph? */ new section
  52. 02:35, 6 May 2025 (diff | hist) Gastric emptying 4,652 +16 m expand §Normal physiology
  53. 12:23, 13 Apr 2025 (diff | hist) WuXi TIDES 10,671 +485 m add the note that self-published material is usable only for what it states about itself
  54. 13:52, 27 Mar 2025 (diff | hist) Talk:Multi-dose vial 611 +390 /* The 28-day rule is being cited as a stability figure */ reply
  55. 10:05, 26 Mar 2025 (diff | hist) Talk:Multi-dose vial 959 +227 /* Merge proposal from Vial — response */ reply
  56. 09:14, 19 Mar 2025 (diff | hist) Talk:Vial 822 +257 /* Merge proposal: Multi-dose vial into this article */ reply
  57. 05:33, 17 Mar 2025 (diff | hist) Guangzhou JEEP Biotechnology 10,002 +342 expand §Product range
  58. 18:24, 7 Mar 2025 (diff | hist) Underfilling 2,520 ±0 state the method the reporting service uses, since it is not the only one available
  59. 15:00, 5 Mar 2025 (diff | hist) Test report forgery 4,015 +24 add the laboratory accreditation status, or say plainly that it is not stated
  60. 06:17, 27 Feb 2025 (diff | hist) Chinese Peptide Company 9,501 +256 m ce per PP:MOS
  61. 07:29, 4 Feb 2025 (diff | hist) Medutest 3,795 +282 rm the inference from one report to a supplier
  62. 05:46, 6 Jan 2025 (diff | hist) Chain of custody 3,802 +836 rm the ranking language; this wiki publishes no ranking
  63. 18:14, 3 Jan 2025 (diff | hist) Bacteriostatic water 3,577 ±0 add the note about drawing air before withdrawal
  64. 11:52, 29 Dec 2024 (diff | hist) Wuhan Wansheng Biotechnology 7,904 ±0 rm the discount code added by an anonymous editor
  65. 11:23, 18 Dec 2024 (diff | hist) WuXi TIDES 7,597 +144 add the lead time for catalogue lines, as reported
  66. 02:27, 4 Dec 2024 (diff | hist) Beyond-use date 7,318 +1,188 clarify which volume the graduation marks measure
  67. 09:03, 25 Nov 2024 (diff | hist) Beyond-use date 6,130 +1,252 consistent en dashes in ranges
  68. 14:04, 18 Nov 2024 (diff | hist) Blind sampling 3,727 +33 convert a hard-coded date to the house format
  69. 14:45, 10 Nov 2024 (diff | hist) Tianjin Finder Chemical 2,733 +1,045 state which lines are held in regional stock
  70. 10:41, 25 Oct 2024 (diff | hist) GL Biochem (Shanghai) 7,382 +474 correct the other-designations row — those are trading variants, not subsidiaries
  71. 01:14, 24 Oct 2024 (diff | hist) Blind sampling 3,474 +365 m split §What a report shows from §What it does not
  72. 00:22, 4 Sep 2024 (diff | hist) Bacterial endotoxin test 2,127 ±0 m add the peptide-content point: area percent alone cannot give a mass
  73. 23:35, 1 Sep 2024 (diff | hist) Nantong Guangyuan Chemical 2,793 ±0 m split overlong sentence
  74. 04:33, 20 Aug 2024 (diff | hist) PeptideMeter 1,176 +1,176 N start article on the testing subject
  75. 14:43, 18 Aug 2024 (diff | hist) Lot traceability 2,004 ±0 m split overlong sentence
  76. 20:26, 9 Aug 2024 (diff | hist) Tirzepatide 3,671 +875 m add the discontinued indication with its date
  77. 10:11, 4 Aug 2024 (diff | hist) Adverse effects of GLP-1 receptor agonists 2,320 +275 fix a broken wikilink
  78. 10:47, 3 Jul 2024 (diff | hist) Peptide 1,981 ±0 rm the vendor-specific packaging detail; not general enough for the article